
TY  - JOUR
TI  - SIOP Abstracts
JO  - Medical and Pediatric Oncology
JA  - Med. Pediatr. Oncol.
VL  - 39
IS  - 4
SN  - 0098-1532
UR  - https://doi.org/10.1002/mpo.10223
DO  - doi:10.1002/mpo.10223
SP  - 220
EP  - 423
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts - Oral and Poster Presentations from the XII International Congress of Dermatology April 18-22, 2017 - Buenos Aires, Argentina
JO  - International Journal of Dermatology
JA  - Int J Dermatol
VL  - 56
IS  - 11
SN  - 0011-9059
UR  - https://doi.org/10.1111/ijd.13720
DO  - doi:10.1111/ijd.13720
SP  - 1204
EP  - 1316
PY  - 2017
ER  - 

TY  - JOUR
TI  - Supplement Article
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 185
IS  - S1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.15854
DO  - doi:10.1111/bjh.15854
SP  - 3
EP  - 202
PY  - 2019
ER  - 

TY  - JOUR
TI  - Speaker Abstracts
JO  - Child: Care, Health and Development
VL  - 36
IS  - s1
SN  - 0305-1862
UR  - https://doi.org/10.1111/j.1365-2214.2009.01058.x
DO  - doi:10.1111/j.1365-2214.2009.01058.x
SP  - 5
EP  - 38
PY  - 2010
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 65
IS  - S1
SN  - 0002-8614
UR  - https://doi.org/10.1111/jgs.14915
DO  - doi:10.1111/jgs.14915
SP  - S1
EP  - S289
PY  - 2017
ER  - 

TY  - JOUR
TI  - American Society of Pediatric Hematology/Oncology 22nd Annual Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 52
IS  - 6
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.21972
DO  - doi:10.1002/pbc.21972
SP  - 691
EP  - 747
PY  - 2009
ER  - 

TY  - JOUR
TI  - ePoster Sessions
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 21
IS  - s1
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.12496
DO  - doi:10.1111/ene.12496
SP  - 104
EP  - 387
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster abstracts
JO  - Vox Sanguinis
VL  - 93
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2007.00932.x
DO  - doi:10.1111/j.1423-0410.2007.00932.x
SP  - 54
EP  - 274
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Mycoses
JA  - Mycoses
VL  - 58
IS  - S4
SN  - 0933-7407
UR  - https://doi.org/10.1111/myc.12380
DO  - doi:10.1111/myc.12380
SP  - 51
EP  - 226
PY  - 2015
ER  - 

TY  - JOUR
AU  - Martel, P.
AU  - Gilbert, D.
AU  - Labeille, B.
AU  - Kanitakis, J.
AU  - Joly, P.
TI  - A case of paraneoplastic pemphigus with antidesmoglein 1 antibodies as determined by immunoblotting
JO  - British Journal of Dermatology
VL  - 142
IS  - 4
SN  - 0007-0963
UR  - https://doi.org/10.1046/j.1365-2133.2000.03433.x
DO  - doi:10.1046/j.1365-2133.2000.03433.x
SP  - 812
EP  - 813
PY  - 2000
ER  - 

TY  - JOUR
TI  - 29th Annual Meeting of the Wound Healing Society, SAWC-Spring/WHS Joint Meeting: San Diego Convention Center, San Diego, California, USA, April 5–9, 2017
JO  - Wound Repair and Regeneration
JA  - Wound Rep and Reg
VL  - 25
IS  - 4
SN  - 1067-1927
UR  - https://doi.org/10.1111/wrr.12573
DO  - doi:10.1111/wrr.12573
SP  - A1
EP  - A47
PY  - 2017
ER  - 

TY  - JOUR
TI  - Foot & mouth disease
JO  - Clinical Microbiology and Infection
VL  - 8
IS  - s1
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2002.tb00013.x
DO  - doi:10.1111/j.1469-0691.2002.tb00013.x
SP  - 1
EP  - 394
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 171
IS  - S1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.13753
DO  - doi:10.1111/bjh.13753
SP  - 1
EP  - 88
PY  - 2015
ER  - 

AU  - Musser, John H.
C7  - pp. 203-248
TI  - Carbohydrate-Based Therapeutics
SN  - 9780470278154
UR  - https://doi.org/10.1002/0471266949.bmc026
DO  - doi:10.1002/0471266949.bmc026
SP  - 203-248
KW  - carbohydrate
KW  - glyconjugate
KW  - glycoside
KW  - lectin
KW  - saccharide
KW  - sugar
PY  - 2015
AB  - Abstract Carbohydrates have emerged as a significant new approach to drug discovery. The impact can be seen in the carbohydrate-based therapeutics recently approved for marketing. For example, the trend with low molecular weight heparin-based products has culminated in the approval of a synthetic pentasaccharide for preventing venous thromboembolism after orthopedic surgery. Also, in the treatment of viral infection, two monosaccharide glycomimetic drugs that block neuraminidase are now available for the treatment of influenza. Indeed, at least two new carbohydrate-based drugs were approved on an annual basis as therapeutics during the last decade. Considering the carbohydrate therapeutics now in development, this pace should continue. To continue long term, several objectives must be reached. Technologies to supply carbohydrates in quality and quantity must be refined or discovered. This includes any combination of automated, solid and solution phase, and enzymatic synthesis. Work demonstrating that carbohydrate multivalency is a successful approach to drug discovery needs to be done. Likewise, examples that illustrate how carbohydrate-based libraries can accelerate drug discovery are also needed. An important factor for the success of carbohydrate-based therapeutics in the last decade is the combination of glycobiology and carbohydrate chemistry.
ER  - 

TY  - JOUR
AU  - Bianchi, Marco E.
AU  - Manfredi, Angelo A.
TI  - High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
JO  - Immunological Reviews
VL  - 220
IS  - 1
SN  - 9780470278154
UR  - https://doi.org/10.1111/j.1600-065X.2007.00574.x
DO  - doi:10.1111/j.1600-065X.2007.00574.x
SP  - 35
EP  - 46
KW  - cell death
KW  - alarmins
KW  - cross-presentation
KW  - dendritic cells
KW  - autoimmunity
PY  - 2007
AB  - Summary: Tissue damage occurs often in the life of mammals and is usually repaired. Dying cells are swiftly phagocytosed, but before disappearing, they alert surrounding cells to activate homeostatic programs. They release signals that recruit inflammatory cells to the site of injury, promote cell migration and cell division to replace dead cells, and activate the immune system in anticipation of microbial invasion. Many of these events involve high-mobility group box 1 protein (HMGB1), a nuclear protein that is released passively when necrotic cells lose the integrity of their membranes. HMGB1 behaves as a trigger of inflammation, attracting inflammatory cells, and of tissue repair, recruiting stem cells and promoting their proliferation. Moreover, HMGB1 activates dendritic cells (DCs) and promotes their functional maturation and their response to lymph node chemokines. Activated leukocytes actively secrete HMGB1 in the microenvironment. Thus, HMGB1 acts in an autocrine/paracrine fashion and sustains long-term repair and defense programs. DCs secrete HMGB1 several hours after contact with the first maturation stimulus; HMGB1 secretion is critical for their ability to reach the lymph nodes, to sustain the proliferation of antigen-specific T cells, to prevent their activation-dependent apoptosis, and to promote their polarization towards a T-helper 1 phenotype. These immune responses will also be directed against self-antigens that DCs process at the time of injury and can lead to autoimmunity.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Stroke
VL  - 3
IS  - s1
SN  - 9780470278154
UR  - https://doi.org/10.1111/j.1747-4949.2008.00231.x
DO  - doi:10.1111/j.1747-4949.2008.00231.x
SP  - 2
EP  - 474
PY  - 2008
ER  - 

TY  - JOUR
TI  - Posters: Session A, Monday, 12 July 2004, 17.00–18.00
JO  - Vox Sanguinis
VL  - 87
IS  - s3
SN  - 9780470278154
UR  - https://doi.org/10.1111/j.1423-0410.2004.00517.x
DO  - doi:10.1111/j.1423-0410.2004.00517.x
SP  - 17
EP  - 92
PY  - 2004
ER  - 

TY  - JOUR
TI  - Abstracts Programme
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 21
IS  - S1
SN  - 9780470278154
UR  - https://doi.org/10.1002/ejhf.1488
DO  - doi:10.1002/ejhf.1488
SP  - 5
EP  - 592
PY  - 2019
ER  - 

TY  - JOUR
TI  - SUBJECT INDEX
JO  - Annals of the New York Academy of Sciences
JA  - Annals of the New York Academy of Sciences
VL  - 634
IS  - 1
SN  - 9780470278154
UR  - https://doi.org/10.1111/j.1749-6632.1992.tb00009.x
DO  - doi:10.1111/j.1749-6632.1992.tb00009.x
SP  - 181
EP  - 577
PY  - 1992
ER  - 

TY  - JOUR
TI  - Poster Discussion Sessions
JO  - Allergy
VL  - 65
IS  - s92
SN  - 9780470278154
UR  - https://doi.org/10.1111/j.1398-9995.2010.02392.x
DO  - doi:10.1111/j.1398-9995.2010.02392.x
SP  - 78
EP  - 208
PY  - 2010
ER  - 
